| Company/Division name | AbbVie |
| Parent company | AbbVie |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 50 |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2028 |
| Capital investment ($): | 195 |
| City reshored to: | North Chicago |
| State(s) reshored to: | IL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Impact on domestic economy, Infrastructure, Proximity to customers/market, Skilled workforce availability/training |
